• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实践:高血氨症的管理。

Clinical practice: the management of hyperammonemia.

机构信息

Kinderspital Zurich, Division of Metabolism, University Children's Hospital Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland.

出版信息

Eur J Pediatr. 2011 Jan;170(1):21-34. doi: 10.1007/s00431-010-1369-2. Epub 2010 Dec 17.

DOI:10.1007/s00431-010-1369-2
PMID:21165747
Abstract

Hyperammonemia is a life-threatening condition which can affect patients at any age. Elevations of ammonia in plasma indicate its increased production and/or decreased detoxification. The hepatic urea cycle is the main pathway to detoxify ammonia; it can be defective due to an inherited enzyme deficiency or secondary to accumulated toxic metabolites or substrate depletion. Clinical signs and symptoms in hyperammonemia are unspecific but they are mostly neurological. Thus, in any unexplained change in consciousness or in any unexplained encephalopathy, hyperammonemia must be excluded as fast as possible. Any delay in recognition and start of treatment of hyperammonemia may have deleterious consequences for the patient. Treatment largely depends on the underlying cause but is, at least in pediatric patients, mainly aimed at establishing anabolism to avoid endogenous protein breakdown and amino acid imbalances. In addition, pharmacological treatment options exist to improve urea cycle function or to remove nitrogen, but their use depend on the underlying disorder. To improve the prognosis of acute hyperammonemia, an increased awareness of this condition is probably more needed than anything else. Likewise, the immediate start of appropriate therapy is of utmost importance. This review focuses on a better understanding of factors leading to ammonia elevations and on practical aspects related to diagnosis and treatment in order to improve clinical management of hyperammonemia.

摘要

高氨血症是一种危及生命的疾病,可发生于任何年龄的患者。血浆中氨升高表明其产生增加和/或解毒减少。肝脏尿素循环是解毒氨的主要途径;由于遗传酶缺陷或累积毒性代谢物或底物耗竭,其可能发生缺陷。高氨血症的临床体征和症状无特异性,但大多为神经症状。因此,在任何原因不明的意识改变或任何原因不明的脑病中,必须尽快排除高氨血症。对高氨血症的识别和治疗的任何延迟都可能对患者产生有害影响。治疗主要取决于潜在病因,但至少在儿科患者中,主要目的是建立合成代谢以避免内源性蛋白质分解和氨基酸失衡。此外,存在改善尿素循环功能或去除氮的药物治疗选择,但它们的使用取决于潜在疾病。为了改善急性高氨血症的预后,可能比任何其他因素都更需要提高对这种疾病的认识。同样,立即开始适当的治疗至关重要。这篇综述重点介绍了导致氨升高的因素以及与诊断和治疗相关的实际方面,以改善高氨血症的临床管理。

相似文献

1
Clinical practice: the management of hyperammonemia.临床实践:高血氨症的管理。
Eur J Pediatr. 2011 Jan;170(1):21-34. doi: 10.1007/s00431-010-1369-2. Epub 2010 Dec 17.
2
Hyperammonemia in review: pathophysiology, diagnosis, and treatment.高血氨血症综述:病理生理学、诊断和治疗。
Pediatr Nephrol. 2012 Feb;27(2):207-22. doi: 10.1007/s00467-011-1838-5. Epub 2011 Mar 23.
3
Primary hyperammonaemia: Current diagnostic and therapeutic strategies.原发性高血氨症:当前的诊断和治疗策略。
J Mother Child. 2020 Oct 2;24(2):32-38. doi: 10.34763/jmotherandchild.20202402si.2015.000006.
4
Inborn Errors of Metabolism with Hyperammonemia: Urea Cycle Defects and Related Disorders.伴有高氨血症的先天性代谢缺陷:尿素循环障碍及相关疾病
Pediatr Clin North Am. 2018 Apr;65(2):231-246. doi: 10.1016/j.pcl.2017.11.004. Epub 2018 Feb 2.
5
Clinical and biochemical aspects of primary and secondary hyperammonemic disorders.原发性和次发性高氨血症疾病的临床和生化方面。
Arch Biochem Biophys. 2013 Aug 15;536(2):101-8. doi: 10.1016/j.abb.2013.04.009. Epub 2013 Apr 27.
6
Hyperammonemia, bane of the brain.高氨血症,大脑的祸根。
Clin Pediatr (Phila). 2004 Oct;43(8):683-9. doi: 10.1177/000992280404300801.
7
Recent advances in the treatment of hyperammonemia.高氨血症治疗的最新进展。
Adv Drug Deliv Rev. 2015 Aug 1;90:55-68. doi: 10.1016/j.addr.2015.04.009. Epub 2015 Apr 17.
8
Hyperammonemia in urea cycle disorders: role of the nephrologist.尿素循环障碍中的高氨血症:肾病学家的作用。
Am J Kidney Dis. 2001 May;37(5):1069-80. doi: 10.1016/s0272-6386(05)80026-5.
9
Urea cycle disorders.尿素循环障碍
Semin Neonatol. 2002 Feb;7(1):27-35. doi: 10.1053/siny.2001.0085.
10
Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients.器官移植患者高血氨症的病理生理学和治疗管理。
Am J Kidney Dis. 2019 Sep;74(3):390-398. doi: 10.1053/j.ajkd.2019.03.419. Epub 2019 Apr 27.

引用本文的文献

1
Hyperammonaemia in Dogs Presenting with Acute Epileptic Seizures-More than Portosystemic Shunts.患有急性癫痫发作的犬的高氨血症——不止是门体分流。
Animals (Basel). 2025 Aug 30;15(17):2558. doi: 10.3390/ani15172558.
2
Valproate-induced hyperammonemic encephalopathy: the role of clinical pharmacists in medication safety-a case report.丙戊酸盐所致高氨血症性脑病:临床药师在用药安全中的作用——病例报告
J Med Case Rep. 2025 Jul 1;19(1):302. doi: 10.1186/s13256-025-05294-z.
3
Safety evaluation of irinotecan: a real-world disproportionality analysis using FAERS and JADER databases during the time period 2004-2024.

本文引用的文献

1
Diffusion tensor imaging detects areas of abnormal white matter microstructure in patients with partial ornithine transcarbamylase deficiency.弥散张量成像检测到部分鸟氨酸转氨甲酰酶缺乏症患者的白质微观结构异常区域。
AJNR Am J Neuroradiol. 2010 Oct;31(9):1719-23. doi: 10.3174/ajnr.A2122. Epub 2010 May 20.
2
New insights in nutritional management and amino acid supplementation in urea cycle disorders.尿素循环障碍的营养管理和氨基酸补充的新见解。
Mol Genet Metab. 2010;100 Suppl 1(Suppl 1):S72-6. doi: 10.1016/j.ymgme.2010.02.019. Epub 2010 Mar 1.
3
Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine.
伊立替康的安全性评估:2004年至2024年期间使用FAERS和JADER数据库进行的真实世界不成比例性分析。
Front Pharmacol. 2025 Jun 9;16:1516449. doi: 10.3389/fphar.2025.1516449. eCollection 2025.
4
Characterization and treatment monitoring of ureagenesis disorders using stable isotopes.使用稳定同位素对尿素生成障碍进行表征和治疗监测。
NPJ Metab Health Dis. 2025;3(1):19. doi: 10.1038/s44324-025-00051-8. Epub 2025 May 6.
5
Asparaginase-associated hyperammonemia.天冬酰胺酶相关性高氨血症
Haematologica. 2025 Aug 1;110(8):1702-1709. doi: 10.3324/haematol.2025.287301. Epub 2025 Apr 24.
6
Comparative efficacy of levofloxacin, azithromycin, and doxycycline prophylaxis and treatment in an experimental murine lung infection model.左氧氟沙星、阿奇霉素和多西环素在实验性小鼠肺部感染模型中的预防及治疗效果比较
Antimicrob Agents Chemother. 2025 May 7;69(5):e0172424. doi: 10.1128/aac.01724-24. Epub 2025 Apr 14.
7
Novel roles of ammonia in physiology and cancer.氨在生理学和癌症中的新作用。
J Mol Cell Biol. 2025 Mar 6. doi: 10.1093/jmcb/mjaf007.
8
Role of carglumic acid in the long-term management of propionic and methylmalonic acidurias.卡谷氨酸在丙酸血症和甲基丙二酸血症长期管理中的作用。
Orphanet J Rare Dis. 2024 Dec 18;19(1):464. doi: 10.1186/s13023-024-03468-4.
9
Prognostic value of serum ammonia in critical patients with non-hepatic disease: A prospective, observational, multicenter study.血清氨在非肝脏疾病危重症患者中的预后价值:一项前瞻性、观察性、多中心研究。
J Transl Int Med. 2022 Jul 2;11(4):401-409. doi: 10.2478/jtim-2022-0021. eCollection 2023 Dec.
10
Genetic background and clinical characteristics of infantile hyperammonemia.婴儿高氨血症的遗传背景和临床特征
Transl Pediatr. 2023 May 30;12(5):882-889. doi: 10.21037/tp-22-359. Epub 2023 Apr 24.
氨对大脑的毒性:对肌酸代谢和转运的影响以及肌酸的保护作用。
Mol Genet Metab. 2010;100 Suppl 1:S53-8. doi: 10.1016/j.ymgme.2010.02.011. Epub 2010 Feb 14.
4
Current concepts in the pathogenesis of urea cycle disorders.尿素循环障碍发病机制的当前概念。
Mol Genet Metab. 2010;100 Suppl 1:S3-S12. doi: 10.1016/j.ymgme.2010.02.010. Epub 2010 Feb 14.
5
Brain imaging in urea cycle disorders.脑成像在尿素循环障碍中的应用。
Mol Genet Metab. 2010;100 Suppl 1(Suppl 1):S20-30. doi: 10.1016/j.ymgme.2010.01.017. Epub 2010 Feb 13.
6
Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity.氧化应激、星形胶质细胞肿胀与脑氨毒性的相互作用。
Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):87-92. doi: 10.1097/MCO.0b013e328333b829.
7
Ammonia toxicity and its prevention in inherited defects of the urea cycle.氨中毒及其在尿素循环遗传缺陷中的预防。
Diabetes Obes Metab. 2009 Sep;11(9):823-35. doi: 10.1111/j.1463-1326.2009.01054.x. Epub 2009 Jun 16.
8
Profiling of astrocyte properties in the hyperammonaemic brain: shedding new light on the pathophysiology of the brain damage in hyperammonaemia.高氨血症大脑中星形胶质细胞特性的剖析:为高氨血症脑损伤的病理生理学带来新见解。
J Inherit Metab Dis. 2008 Aug;31(4):492-502. doi: 10.1007/s10545-008-0834-9. Epub 2008 Aug 9.
9
1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency.1H磁共振波谱法可识别出患有部分鸟氨酸转氨甲酰酶缺乏症的有症状和无症状受试者。
Mol Genet Metab. 2008 Sep-Oct;95(1-2):21-30. doi: 10.1016/j.ymgme.2008.06.003. Epub 2008 Jul 26.
10
Cross-sectional multicenter study of patients with urea cycle disorders in the United States.美国尿素循环障碍患者的横断面多中心研究。
Mol Genet Metab. 2008 Aug;94(4):397-402. doi: 10.1016/j.ymgme.2008.05.004. Epub 2008 Jun 17.